News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,603 Results
Type
Article (2069)
Company Profile (22)
Press Release (67512)
Section
Business (31511)
Career Advice (50)
Deals (5100)
Drug Delivery (1)
Drug Development (8244)
Employer Resources (16)
FDA (1249)
Job Trends (1789)
News (44030)
Policy (2371)
Tag
Academia (133)
Academic (1)
Allergies (8)
Alliances (2521)
ALS (5)
Alzheimer's disease (137)
Antibody-drug conjugate (ADC) (20)
Approvals (1307)
Artificial intelligence (27)
Autoimmune disease (4)
Bankruptcy (19)
Best Places to Work (1670)
Biosimilars (7)
Biotechnology (17)
Bladder cancer (25)
Brain cancer (4)
Breast cancer (85)
Cancer (501)
Cardiovascular disease (36)
Career advice (44)
CAR-T (10)
CDC (2)
Cell therapy (35)
Cervical cancer (6)
Clinical research (7634)
Collaboration (69)
Compensation (56)
COVID-19 (151)
CRISPR (5)
C-suite (17)
Cystic fibrosis (13)
Data (724)
Depression (4)
Diabetes (36)
Diagnostics (666)
Digital health (5)
Diversity, equity & inclusion (4)
Drug discovery (14)
Drug pricing (7)
Duchenne muscular dystrophy (9)
Earnings (28681)
Employer branding (2)
Employer resources (13)
Events (7183)
Executive appointments (29)
FDA (1716)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (4)
Funding (67)
Gene editing (11)
Generative AI (3)
Gene therapy (49)
GLP-1 (99)
Government (279)
Guidances (261)
Healthcare (2182)
HIV (7)
Huntington's disease (1)
IgA nephropathy (9)
Immunology and inflammation (20)
Immuno-oncology (2)
Indications (9)
Infectious disease (170)
Inflammatory bowel disease (20)
Inflation Reduction Act (1)
Influenza (7)
Intellectual property (11)
Interviews (7)
IPO (3922)
IRA (1)
Job creations (207)
Job search strategy (43)
Kidney cancer (5)
Labor market (8)
Layoffs (30)
Legal (451)
Liver cancer (11)
Lung cancer (82)
Lymphoma (41)
Machine learning (2)
Management (3)
Manufacturing (30)
MASH (20)
Medical device (1614)
Medtech (1618)
Mergers & acquisitions (1263)
Metabolic disorders (115)
Multiple sclerosis (23)
NASH (2)
Neurodegenerative disease (12)
Neuropsychiatric disorders (9)
Neuroscience (215)
NextGen: Class of 2025 (550)
Non-profit (282)
Now hiring (1)
Obesity (48)
Opinion (11)
Ovarian cancer (11)
Pain (7)
Pancreatic cancer (21)
Parkinson's disease (17)
Partnered (3)
Patents (25)
Patient recruitment (21)
Peanut (4)
People (2127)
Pharmaceutical (4)
Pharmacy benefit managers (3)
Phase I (1822)
Phase II (3035)
Phase III (3243)
Pipeline (1042)
Policy (9)
Postmarket research (341)
Preclinical (577)
Press Release (1)
Prostate cancer (24)
Radiopharmaceuticals (21)
Rare diseases (58)
Real estate (292)
Recruiting (7)
Regulatory (1939)
Reports (12)
Research institute (156)
Resumes & cover letters (5)
Rett syndrome (2)
RNA editing (2)
RSV (8)
Schizophrenia (16)
Series A (10)
Series B (8)
Service/supplier (1)
Sickle cell disease (11)
Special edition (3)
Spinal muscular atrophy (6)
Startups (147)
Stomach cancer (4)
Supply chain (3)
Tariffs (4)
The Weekly (2)
Vaccines (91)
Venture capital (1)
Weight loss (32)
Women's health (4)
Date
Today (1)
Last 7 days (126)
Last 30 days (312)
Last 365 days (4426)
2025 (3573)
2024 (5259)
2023 (5834)
2022 (6767)
2021 (7020)
2020 (6180)
2019 (4567)
2018 (3450)
2017 (3268)
2016 (2335)
2015 (3062)
2014 (2028)
2013 (1320)
2012 (1753)
2011 (2002)
2010 (1880)
Location
Africa (59)
Alabama (6)
Arizona (14)
Arkansas (2)
Asia (3577)
Australia (603)
California (1283)
Canada (371)
China (85)
Colorado (63)
Connecticut (77)
Delaware (50)
Europe (10135)
Florida (164)
Georgia (55)
Idaho (3)
Illinois (71)
India (3)
Indiana (95)
Iowa (1)
Japan (35)
Kansas (9)
Kentucky (6)
Louisiana (6)
Maine (14)
Maryland (143)
Massachusetts (832)
Michigan (30)
Minnesota (70)
Missouri (11)
Montana (3)
Nebraska (3)
Nevada (7)
New Hampshire (9)
New Jersey (445)
New Mexico (1)
New York (381)
North Carolina (165)
Northern California (655)
Ohio (26)
Oregon (2)
Pennsylvania (253)
South America (89)
South Carolina (1)
Southern California (476)
Tennessee (27)
Texas (178)
United States (4559)
Utah (37)
Virginia (12)
Washington D.C. (5)
Washington State (135)
Wisconsin (8)
69,603 Results for "47".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HanchorBio Secures US Patent for Innovative SIRPα/CD47 Fusion Protein HCB101
October 21, 2025
·
4 min read
Press Releases
Pinetree Therapeutics Raises $47 Million in Oversubscribed Series B to Advance Next-Generation Protein Degraders in Oncology
October 28, 2025
·
4 min read
Press Releases
HanchorBio’s Novel CD47-SIRPα Therapeutic HCB101 Accepted for Publication in Prestigious Journal of Hematology & Oncology
October 23, 2025
·
5 min read
Press Releases
smartbax announces a €4.7 M Pre-Series A round to advance novel antibiotic compound through preclinical stage
October 22, 2025
·
8 min read
Press Releases
Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025
October 27, 2025
·
3 min read
Press Releases
Maryland Stem Cell Research Fund Awards $4.7 million to Support Innovations in Stem Cell Research
October 3, 2025
·
4 min read
Press Releases
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
October 31, 2025
·
2 min read
Press Releases
Akeso’s Ligufalimab (CD47 mAb) Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia (AML)
September 16, 2025
·
6 min read
Press Releases
Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity
August 18, 2025
·
3 min read
Press Releases
Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy
September 22, 2025
·
9 min read
1 of 6,961
Next
